65,437 trials
End Stage Renal Disease · Chronic Kidney Disease
Primary: Incidence of Treatment-emergent Adverse Events — 31.6; 35.1; 95.1 percentage of participants
Depression · Melancholia
Primary: HAMILTON Rating Scale for DEPRESSION Range — 27.3; 27.1; 10.7; 8.4 units on a scale — p=<0.05
Rectal Neoplasms
Primary: Number of Participants Experienced Dose Limited Toxicity — 0; 1; 1; 0 participants
Healthy
Primary: Number of Participants With Positive Responses to Palatability Assessment of The Taste of Mesalamine — 17; 16; 13 participants
Plaque Psoriasis
Primary: The Difference in Bilateral Static Physician's Global Assessment (sPGA) Scores, and Erythema, Scaling, and Induration (ESI) Scores of Bilateral Target Lesion Scores…
Ulcerative Colitis · Crohns Disease
Primary: Score of Crohn´s Disease and/or Ulcerative Colitis — 58; 1.8; 43; 1.2 units on a scale
Pandemic H5N1 Influenza
Primary: The Percentages Of Subjects Aged 6 to <36 Months, Achieving Hemagglutination Inhibition (HI) Titers ≥40 Against A/H5N1 Strain — 1; 0; 98; 94 Percentages of subjects
Kidney Stone
Primary: Number of Participants Who Are Stone Free at 3 Months — 54; 49 participants
Fluid Overload · Anesthesia; Adverse Effect, Spinal and Epidural · Regional Anesthesia Morbidity
Primary: Rate of Arterial Hypotension — 42.5; 27.5 percentage of participants
Wrinkles
Primary: Keloid Formation at Site of Injection — 0.0 percentage of participants
Chronic Sinusitis
Primary: Safety as Determined by the Frequency of Serious Adverse Local Tissue Response (SALT) — 6 Number of Sinuses
Glioma, Motor Pathway
Primary: Extent of Tumor Resection — 40; 7; 7; 4 participants
Bipolar Disorder · Depression
Primary: Mania Rating Scale — 4.54; 5.57 units on a scale
Malignant Pleural Mesothelioma
Primary: To Determine the Rate of Clinical Benefit (i.e. Rate of Complete or Partial Response Plus Stable Disease) at 16 Weeks for Patients With Malignant Mesothelioma Treated…
Diabetic Macular Edema
Primary: Change From Baseline in Best Corrected Visual Acuity (BCVA) as Measured by Early Treatment Diabetic Retinopathy Study (ETDRS) Letter Score at Week 52 - Last Observation…